Cord Blood Release Track Record
Total Releases
85
Allogeneic
35
Autologous
50
Thalassaemia
Major
20
Autism Spectrum Disorder (ASD)
21
Leukaemia
10
Cerebral Palsy
19
- Neuroblastoma: 3
- Brain Injury: 2
- Hypoxic-Ischemic Encephalopathy: 3
- Fanconi Anaemia: 1
- Sickle Cell Anaemia: 1
- Global Development Delay: 1
- Developmental Dyspraxia: 1
- Aplastic Anaemia: 1
The table below features the cord blood releases performed by Cordlife Group Limited and its subsidiaries. As a Group, Cordlife has made 85 cord blood releases, all of which have been used successfully in transplants or cellular therapy. This is the ultimate validation of our cord blood processing and storage capability.
| NO | RELEASE | Banked By | MEDICAL CONDITION | RECIPIENT'S RELATIONSHIP | STORAGE TIME (in months) | TREATMENT FACILITY |
|---|---|---|---|---|---|---|
| 1 | 2002 | Cordlife Singapore | Acute Lymphoblastic Leukaemia | Sibling | 5.5 | KK Women's & Children's Hospital |
| 2 | 2002 | Cordlife Singapore | Acute Lymphoblastic Leukaemia | Sibling | 1.1 | KK Women's & Children's Hospital |
| 3 | 2006 | Stemlife Malaysia | Thalassaemia Major | Sibling | N/A | University Malaya Medical Centre |
| 4 | 2006 | Stemlife Malaysia | Acute Myeloid Leukaemia | Sibling | 32.1 | University Malaya Medical Centre |
| 5 | 2007 | Stemlife Malaysia | Acute Lymphoblastic Leukaemia | Sibling | N/A | University Malaya Medical Centre |
| 6 | 2008 | Stemlife Malaysia | Thalassaemia Major | Sibling | 19.4 | University Malaya Medical Centre |
| 7 | 2009 | Cordlife Singapore | Cerebral Palsy | Self | 28.1 | Mount Elizabeth Hospital |
| 8 | 2009 | Stemlife Malaysia | Cerebral Palsy | Self | 38.8 | Private Hospital, Bangkok |
| 9 | 2009 | Stemlife Malaysia | Cerebral Palsy | Self | 30.6 | Private Hospital, Bangkok |
| 10 | 2009 | Stemlife Malaysia | Brain Injury | Self | 11.3 | Private Hospital, Bangkok |
| 11 | 2010 | Stemlife Malaysia | Thalassaemia Major | Sibling | 14.6 | Institut Pediatrik, GHKL |
| 12 | 2010 | Cordlife Singapore | Neuroblastoma | Self | 35.0 | KK Women's & Children's Hospital |
| 13 | 2010 | Cordlife Singapore | Cerebral Palsy | Self | 18.7 | Mount Elizabeth Hospital |
| 14 | 2010 | Healthbaby Hong Kong | Cerebral Palsy | Self | 42.0 | Duke University Hospital |
| 15 | 2010 | Stemlife Malaysia | Thalassaemia Major | Sibling | N/A | Institut Pediatrik, GHKL |
| 16 | 2010 | Stemlife Malaysia | Cerebral Palsy | Self | 14.5 | Private Hospital, Bangkok |
| 17 | 2010 | Stemlife Malaysia | Cerebral Palsy | Self | 7.4 | Private Hospital, Bangkok |
| 18 | 2011 | Cordlife Hong Kong | Neuroblastoma | Self | 29.3 | Queen Mary Hospital |
| 19 | 2011 | Cordlife India | Thalassaemia Major (E beta Thalassaemia) | Sibling | 24.4 | Netaji Subhash Chandra Bose Cancer Research Institute |
| 20 | 2011 | Stemlife Malaysia | Brain Injury | Self | 35.6 | Private Hospital, Bangkok |
| 21 | 2011 | Healthbaby Hong Kong | Cerebral Palsy | Self | 12.5 | Duke University Hospital |
| 22 | 2012 | Cordlife Singapore | Acute Myeloblastic Leukaemia | Sibling | 13.2 | Peking University First Hospital |
| 23 | 2012 | Cordlife Singapore | Cerebral Palsy | Self | 20.6 | Duke University Hospital |
| 24 | 2013 | Stemlife Malaysia | Thalassaemia Major | Sibling | 37.5 | University Malaya Medical Centre |
| 25 | 2013 | Cordlife Singapore | Juvenile Myelomonocytic Leukaemia | Sibling | 4.2 | KK Women's & Children's Hospital |
| 26 | 2013 | Healthbaby Hong Kong | Neuroblastoma | Self | 70.9 | Queen Mary Hospital |
| 27 | 2014 | Cordlife Philippines | Cerebral Palsy | Self | 7.0 | Private Hospital, Philippines |
| 28 | 2014 | Cordlife Singapore | Hypoxic-Ischemic Encephalopathy | Self | 6.0 | Mount Elizabeth Hospital |
| 29 | 2014 | Cordlife Singapore | Cerebral Palsy | Self | 33.8 | CHA Bundang Medical Center |
| 30 | 2014 | Cordlife Singapore | Cerebral Palsy | Self | 33.8 | CHA Bundang Medical Center |
| 31 | 2014 | Healthbaby Hong Kong | Fanconi Anaemia and marrow failure | Sibling | 49.5 | Queen Mary Hospital |
| 32 | 2014 | Cordlife Singapore | Cerebral Palsy | Self | 57.3 | Mount Elizabeth Hospital |
| 33 | 2014 | Stemlife Malaysia | Thalassaemia Major | Sibling | 44.9 | Institut Pediatrik, GHKL |
| 34 | 2015 | Cordlife Singapore | Cerebral Palsy | Self | 21.1 | Mount Elizabeth Hospital |
| 35 | 2015 | Cordlife India | Thalassaemia Major | Sibling | 15.8 | Apollo Speciality Hospital |
| 36 | 2015 | Cordlife Hong Kong | Thalassaemia Major | Sibling | 25.4 | Queen Mary Hospital |
| 37 | 2015 | Stemlife Malaysia | Thalassaemia Major | Sibling | 13.8 | University Malaya Medical Centre |
| 38 | 2015 | Cordlife Singapore | Cerebral Palsy | Self | 26.0 | Mount Elizabeth Hospital |
| 39 | 2015 | Cordlife India | Cerebral Palsy | Self | 19.2 | Duke University Hospital |
| 40 | 2015 | Cordlife Singapore | Cerebral Palsy | Self | 67.3 | Mount Elizabeth Hospital |
| 41 | 2017 | Cordlife India | Thalassaemia Major | Sibling | 63.0 | Tata Medical Center |
| 42 | 2017 | Cordlife Singapore | Cerebral Palsy | Self | 47.9 | Mount Elizabeth Hospital |
| 43 | 2018 | Stemlife Malaysia | Chronic Myeloid Leukaemia | Sibling | 32.9 | University Malaya Medical Centre |
| 44 | 2018 | Cordlife Singapore | Cerebral Palsy | Self | 26.3 | Mount Elizabeth Hospital |
| 45 | 2018 | Cordlife Singapore | Acute Lymphoblastic Leukaemia | Sibling | 119.3 | KK Women's & Children's Hospital |
| 46 | 2019 | Cordlife India | Hypoxic-Ischemic Encephalopathy and Cystic Encephalomalacia | Self | 2.5 | Duke University Hospital |
| 47 | 2019 | Cordlife Singapore | Global Development Delay | Self | 50.1 | Vinmec Research Institute of Stem Cell and Gene Technology (Hanoi) |
| 48 | 2019 | Cordlife Singapore | Autism Spectrum Disorder | Self | 71.5 | Gleneagles Kuala Lumpur |
| 49 | 2019 | Cordlife Singapore | Autism Spectrum Disorder | Self | 92.0 | Gleneagles Kuala Lumpur |
| 50 | 2019 | Cordlife Singapore | Autism Spectrum Disorder | Self | 92.8 | Gleneagles Kuala Lumpur |
| 51 | 2019 | Cordlife Singapore | Autism Spectrum Disorder | Self | 78.4 | KK Women's & Children's Hospital |
| 52 | 2019 | Cordlife India | Thalassaemia Major | Sibling | 22.1 | Dr. Balabhai Nanavati Hospital |
| 53 | 2019 | Cordlife Singapore | Autism Spectrum Disorder | Self | 67.7 | KK Women's & Children's Hospital |
| 54 | 2019 | Stemlife Malaysia | Autism Spectrum Disorder | Self | 133.3 | Gleneagles Kuala Lumpur |
| 55 | 2019 | Cordlife Singapore | Autism Spectrum Disorder | Self | 110.1 | Duke University Hospital |
| 56 | 2019 | Cordlife Singapore | Autism Spectrum Disorder | Self | 47.7 | KK Women's & Children's Hospital |
| 57 | 2019 | Cordlife Singapore | Autism Spectrum Disorder | Self | 112.5 | Gleneagles Kuala Lumpur |
| 58 | 2019 | Stemlife Malaysia | Developmental Dyspraxia | Self | 79.6 | Duke University Hospital |
| 59 | 2019 | Cordlife Singapore | Autism Spectrum Disorder | Self | 54.4 | KK Women's & Children's Hospital |
| 60 | 2019 | Cordlife Singapore | Autism Spectrum Disorder | Self | 59.8 | KK Women's & Children's Hospital |
| 61 | 2020 | Cordlife India | Sickle cell Anaemia | Sibling | 15.2 | Indraprastha Apollo Hospital |
| 62 | 2020 | Cordlife Singapore | Autism Spectrum Disorder | Self | 59.7 | KK Women's & Children's Hospital |
| 63 | 2020 | Cordlife Singapore | Autism Spectrum Disorder | Self | 52.3 | KK Women's & Children's Hospital |
| 64 | 2020 | Cordlife Singapore | Autism Spectrum Disorder | Self | 60.0 | KK Women's & Children's Hospital |
| 65 | 2021 | Cordlife Philippines | Autism Spectrum Disorder | Sibling | 49.4 | KK Women's & Children's Hospital |
| 66 | 2021 | Cordlife India | Thalassaemia Major | Self | 19.5 | Apollo Speciality Hospital |
| 67 | 2021 | Cordlife Singapore | Autism Spectrum Disorder | Self | 45.7 | KK Women's & Children's Hospital |
| 68 | 2021 | Cordlife Singapore | Autism Spectrum Disorder | Self | 65.1 | KK Women's & Children's Hospital |
| 69 | 2021 | Cordlife Singapore | Autism Spectrum Disorder | Self | 63.2 | KK Women's & Children's Hospital |
| 70 | 2021 | Healthbaby Hong Kong | Thalassaemia Major | Sibling | 48.5 | Hong Kong Children's Hospital |
| 71 | 2022 | Cordlife Hong Kong | Hypoxic Ischemic Encephalopathy | Self | 8.4 | Hong Kong Children's Hospital |
| 72 | 2022 | Cordlife Singapore | Aplastic Anaemia | Self | 81.5 | Mount Elizabeth Hospital |
| 73 | 2023 | Cordlife India | Thalassaemia Major | Sibling | 17 | Max Super Speciality Hospital, Delhi |
| 74 | 2023 | Cordlife India | Thalassaemia Major | Sibling | 43 | Narayana Health City, Bangalore |
| 75 | 2023 | Cordlife Indonesia | Autism Spectrum Disorder | Sibling | 6.6 | Celltech Stem Cell Centre |
| 76 | 2023 | Cordlife Philippines | Autism Spectrum Disorder | Self | 52 | Private Hospital, Philippines |
| 77 | 2024 | Stemlife Malaysia | Myelomonocytic Leukaemia | Sibling | 100 | University Malaya Medical Centre |
| 78 | 2024 | Cordlife India | Thalassaemia Major | Sibling | 15 | Apollo Speciality Hospital Chennai |
| 79 | 2024 | Stemlife Malaysia | Acute Myeloid Leukaemia (AML) | Self | 200 | Hospital Ampang |
| 80 | 2025 | Cordlife Indonesia | Heart Disease | Father | 172 | Celltech Stem Cell Centre, Jakarta |
| 81 | 2025 | Cordlife Indonesia | Diabetes Mellitus Type II | Mother | 172 | Celltech Stem Cell Centre, Jakarta |
| 82 | 2025 | Cordlife India | Thalassaemia Major | Sibling | 5 | HCG EKO Cancer Centre, Kolkata |
| 83 | 2026 | Cordlife Philippines | Autism Spectrum Disorder | Sister | 91 | Private Hospital, Philippines |
| 84 | 2026 | Cordlife India | Thalassaemia Major | Sibling | 27 | Narayana Memorial Hospital,Howrah |
| 85 | 2026 | Cordlife India | Thalassaemia Major | Sibling | 42 | Apollo Cancer Hospital Chennai |
Cord blood units sent to South Korea were used for two separate infusions for two children (twins). Some releases may be for the same client but released in different period. This list shows the cord blood released by Cordlife and subsidiaries to support the treatment of various diseases. This should not be used as a reference for the list of treatable diseases by cord blood stem cells. In addition, banking your baby’s cord blood does not guarantee that the stem cells will provide a cure or be applicable for every situation. The use is ultimately determined by the treating physician.
DCR No. 3676, QR 8.1-7-20, Version c